Protective efficacy of a plant-produced beta variant rsars-cov-2 vlp vaccine in golden syrian hamsters

Simple item page
dc.contributor.authorLemmer, Yolandy
dc.contributor.authorChapman, Ros
dc.contributor.authorShaw, Megan L.
dc.date.accessioned2024-11-14T09:26:34Z
dc.date.available2024-11-14T09:26:34Z
dc.date.issued2024
dc.description.abstractIn the quest for heightened protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, we engineered a prototype vaccine utilizing the plant expression system of Nicotiana benthamiana, to produce a recombinant SARS-CoV-2 virus-like particle (VLP) vaccine presenting the S-protein from the Beta (B.1.351) variant of concern (VOC). This innovative vaccine, formulated with either a squalene oil-in-water emulsion or a synthetic CpG oligodeoxynucleotide adjuvant, demonstrated efficacy in a golden Syrian Hamster challenge model. The Beta VLP vaccine induced a robust humoral immune response, with serum exhibiting neutralization not only against SARS-CoV-2 Beta but also cross-neutralizing Delta and Omicron pseudoviruses. Protective efficacy was demonstrated, evidenced by reduced viral RNA copies and mitigated weight loss and lung damage compared to controls. This compelling data instills confidence in the creation of a versatile platform for the local manufacturing of potential pan-sarbecovirus vaccines, against evolving viral threats.
dc.identifier.citationLemmer, Y., Chapman, R., Abolnik, C., Smith, T., Schäfer, G., Hermanus, T., du Preez, I., Goosen, K., Sepotokele, K.M., Gers, S. and Suliman, T., 2024. Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters. Vaccine, 42(4), pp.738-744.
dc.identifier.urihttps://doi.org/10.1016/j.vaccine.2024.01.036
dc.identifier.urihttps://hdl.handle.net/10566/19671
dc.language.isoen
dc.publisherElsevier Ltd
dc.subjectEfficacy
dc.subjectImmunogenicity
dc.subjectPan-sarbecovirus
dc.subjectVirus-like particles
dc.subjectCoronavirus
dc.titleProtective efficacy of a plant-produced beta variant rsars-cov-2 vlp vaccine in golden syrian hamsters
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
lemmer_protective_efficacy_of_a_plant_2024.pdf
Size:
3.28 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Medical Bioscience)